[{"Assets_0_Q2_USD":"128076000000.0","CIK":"14272","CommonStockDividendsPerShareDeclared_1_Q2_USD":"0.45","CommonStockDividendsPerShareDeclared_2_Q2_USD":"0.45","Country":"United States","EarningsPerShareBasic_1_Q2_USD":"-0.04","EarningsPerShareBasic_2_Q2_USD":"-0.38","EarningsPerShareDiluted_1_Q2_USD":"-0.04","EarningsPerShareDiluted_2_Q2_USD":"-0.38","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NYSE","Market Cap":"162365000000.0","MinorityInterest_0_Q2_USD":"66000000.0","NetCashProvidedByUsedInOperatingActivitiesConverted_2_Q2_USD":"8163000000.0","NetIncomeLoss_1_Q2_USD":"-85000000.0","NetIncomeLoss_2_Q2_USD":"-860000000.0","OfficialName":"Bristol-Myers Squibb Company Common Stock","PaymentsOfDividends_2_Q2_USD":"2038000000.0","ProfitLoss_1_Q2_USD":"-80000000.0","ProfitLoss_2_Q2_USD":"-846000000.0","RevenuesConverted_1_Q2_USD":"10129000000.0","RevenuesConverted_2_Q2_USD":"20910000000.0","SP500":"SP500","Sector":"Health Care","StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0_Q2_USD":"49160000000.0","StockholdersEquity_0_Q2_USD":"49094000000.0","Ticker":"BMY","WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":"2263000000.0","WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":"2261000000.0","WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":"2263000000.0","WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":"2261000000.0","filed":"20200806","footnote":null,"form":"10-Q","fp":"Q2","fy":"2020.0","name":"BRISTOL MYERS SQUIBB CO","period":"20200630","qtrs":"2","uom":"USD"}]